Mark Cuban’s Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.
Read the full post on Becker's Hospital Review - Healthcare News
Mark Cuban’s Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.
Read the full post on Becker's Hospital Review - Healthcare News